Poseida Therapeutics Inc
(PSTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 1,435 | 0 | 0 | 0 | 0 |
| Gross Profit | 1,435 | N/A | N/A | N/A | N/A |
| Operating Expenses | 58,396 | 48,716 | 41,590 | 44,879 | 37,464 |
| Operating Income | -56,961 | -17,478 | -41,590 | -44,879 | -37,464 |
| Interest Expense | 1,077 | 840 | 837 | 843 | 838 |
| Other Income | -19 | 19,787 | 3 | 17 | -12 |
| Pre-tax Income | -58,057 | 1,469 | -42,424 | -45,705 | -38,314 |
| Net Income Continuous | -58,057 | 1,469 | -42,424 | -45,705 | -38,314 |
| Net Income | $-58,057 | $1,469 | $-42,424 | $-45,705 | $-38,314 |
| EPS Basic Total Ops | -0.93 | 0.03 | -0.68 | -0.74 | -0.62 |
| EPS Basic Continuous Ops | -0.93 | 0.03 | -0.68 | -0.74 | -0.62 |
| EPS Diluted Total Ops | -0.93 | 0.03 | -0.68 | -0.74 | -0.62 |
| EPS Diluted Continuous Ops | -0.93 | 0.03 | -0.68 | -0.74 | -0.62 |
| EBITDA(a) | $-55,581 | $-47,378 | $-40,250 | $-43,519 | $-36,178 |